170 related articles for article (PubMed ID: 16269426)
1. Differential influence of p38 mitogen activated protein kinase (MAPK) inhibition on acute phase protein synthesis in human hepatoma cell lines.
Westra J; Bijzet J; Doornbos-van der Meer B; van Rijswijk MH; Limburg PC
Ann Rheum Dis; 2006 Jul; 65(7):929-35. PubMed ID: 16269426
[TBL] [Abstract][Full Text] [Related]
2. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor.
Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC
Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374
[TBL] [Abstract][Full Text] [Related]
3. Chemokine production and E-selectin expression in activated endothelial cells are inhibited by p38 MAPK (mitogen activated protein kinase) inhibitor RWJ 67657.
Westra J; Kułdo JM; van Rijswijk MH; Molema G; Limburg PC
Int Immunopharmacol; 2005 Jul; 5(7-8):1259-69. PubMed ID: 15914330
[TBL] [Abstract][Full Text] [Related]
4. Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts.
Westra J; Limburg PC; de Boer P; van Rijswijk MH
Ann Rheum Dis; 2004 Nov; 63(11):1453-9. PubMed ID: 15479895
[TBL] [Abstract][Full Text] [Related]
5. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells.
Ganapathi MK; Rzewnicki D; Samols D; Jiang SL; Kushner I
J Immunol; 1991 Aug; 147(4):1261-5. PubMed ID: 1651357
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells.
Ganapathi MK; Schultz D; Mackiewicz A; Samols D; Hu SI; Brabenec A; Macintyre SS; Kushner I
J Immunol; 1988 Jul; 141(2):564-9. PubMed ID: 2454996
[TBL] [Abstract][Full Text] [Related]
7. Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synovium.
Migita K; Koga T; Komori A; Torigoshi T; Maeda Y; Izumi Y; Sato J; Jiuchi Y; Miyashita T; Yamasaki S; Kawakami A; Nakamura M; Motokawa S; Ishibashi H
J Rheumatol; 2011 Nov; 38(11):2309-17. PubMed ID: 21844139
[TBL] [Abstract][Full Text] [Related]
8. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells.
Gabay C; Genin B; Mentha G; Iynedjian PB; Roux-Lombard P; Guerne PA
Clin Exp Immunol; 1995 May; 100(2):306-13. PubMed ID: 7743670
[TBL] [Abstract][Full Text] [Related]
9. Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3.
Zauberman A; Zipori D; Krupsky M; Ben-Levy R
Oncogene; 1999 Jul; 18(26):3886-93. PubMed ID: 10445852
[TBL] [Abstract][Full Text] [Related]
10. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
[TBL] [Abstract][Full Text] [Related]
11. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
12. [TNFα induced IL-8 production through p38 MAPK- NF-kB pathway in human hepatocellular carcinoma cells].
Wang YH; Xia JL; Wang WM; Yang BW; Cui JF; Wang XD; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):912-6. PubMed ID: 22525504
[TBL] [Abstract][Full Text] [Related]
13. Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cells.
He SF; Wang W; Ren H; Zhao LJ; Qi ZT
Cytokine; 2013 Mar; 61(3):801-7. PubMed ID: 23410505
[TBL] [Abstract][Full Text] [Related]
14. Coronary microembolization induced myocardial contractile dysfunction and tumor necrosis factor-α mRNA expression partly inhibited by SB203580 through a p38 mitogen-activated protein kinase pathway.
Li L; Qu N; Li DH; Wen WM; Huang WQ
Chin Med J (Engl); 2011 Jan; 124(1):100-5. PubMed ID: 21362316
[TBL] [Abstract][Full Text] [Related]
15. Okadaic acid, an inhibitor of protein phosphatases 1 and 2A, inhibits induction of acute-phase proteins by interleukin-6 alone or in combination with interleukin-1 in human hepatoma cell lines.
Ganapathi MK
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):645-8. PubMed ID: 1377908
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway.
Nan JL; Li JJ; He JG
Chin Med J (Engl); 2009 Aug; 122(16):1922-8. PubMed ID: 19781372
[TBL] [Abstract][Full Text] [Related]
17. Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.
Munoz L; Ramsay EE; Manetsch M; Ge Q; Peifer C; Laufer S; Ammit AJ
Eur J Pharmacol; 2010 Jun; 635(1-3):212-8. PubMed ID: 20226180
[TBL] [Abstract][Full Text] [Related]
18. The sphingomyelin-ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not alpha-fibrinogen.
Lozanski G; Berthier F; Kushner I
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):271-5. PubMed ID: 9359864
[TBL] [Abstract][Full Text] [Related]
19. Polyriboinosinic-polyribocytidylic acid facilitates interleukin-6, and interleukin-8 secretion in human dermal fibroblasts via the JAK/STAT3 and p38 MAPK signal transduction pathways.
Zhu ZY; Jia CZ; Luo JM; Wang L
Cytokine; 2018 Feb; 102():1-6. PubMed ID: 29245047
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
Page TH; Brown A; Timms EM; Foxwell BM; Ray KP
Arthritis Rheum; 2010 Nov; 62(11):3221-31. PubMed ID: 20589681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
